ARCHIVES

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

April 26, 1974

NCI Advisory Group, Other Cancer Meetings

August 16, 1985

ASCO 2014: Special Awards

May 30, 2014

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

16 Institutions Win NCI Awards for Phase I Trials

May 2, 2003